These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1977095

  • 1. Role of arachidonic acid or its metabolites in growth-hormone-releasing factor-induced release of somatostatin from the median eminence.
    Aguila MC, Milenkovic L, McCann SM, Snyder GD.
    Neuroendocrinology; 1990 Sep; 52(3):238-42. PubMed ID: 1977095
    [Abstract] [Full Text] [Related]

  • 2. Calmodulin dependence of somatostatin release stimulated by growth hormone-releasing factor.
    Aguila MC, McCann SM.
    Endocrinology; 1988 Jul; 123(1):305-9. PubMed ID: 2898360
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of somatostatin release in vitro by synthetic human growth hormone-releasing factor by a nondopaminergic mechanism.
    Aguila MC, McCann SM.
    Endocrinology; 1985 Aug; 117(2):762-5. PubMed ID: 2862013
    [Abstract] [Full Text] [Related]

  • 4. The effect of galanin on growth hormone-releasing factor and somatostatin release from median eminence fragments in vitro.
    Aguila MC, Marubayashi U, McCann SM.
    Neuroendocrinology; 1992 Dec; 56(6):889-94. PubMed ID: 1285434
    [Abstract] [Full Text] [Related]

  • 5. Rat growth hormone-releasing factor stimulates cyclic GMP formation and phosphatidylinositol metabolism in the median eminence.
    Aguila MC, Snyder GD, McCann SM.
    Life Sci; 1991 Dec; 49(1):67-74. PubMed ID: 1675756
    [Abstract] [Full Text] [Related]

  • 6. Transmembrane signals mediating neural peptide secretion: role of protein kinase C activators and arachidonic acid metabolites in luteinizing hormone-releasing hormone secretion.
    Negro-Vilar A, Conte D, Valenca M.
    Endocrinology; 1986 Dec; 119(6):2796-802. PubMed ID: 3096697
    [Abstract] [Full Text] [Related]

  • 7. Evidence that growth hormone-releasing factor stimulates somatostatin release in vitro via beta-endorphin.
    Aguila MC, McCann SM.
    Endocrinology; 1987 Jan; 120(1):341-4. PubMed ID: 2877865
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor I modulates hypothalamic somatostatin through a growth hormone releasing factor increased somatostatin release and messenger ribonucleic acid levels.
    Aguila MC, Boggaram V, McCann SM.
    Brain Res; 1993 Oct 22; 625(2):213-8. PubMed ID: 7903898
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone releasing factor (GRF) increases free arachidonate levels in the pituitary: a role for lipoxygenase products.
    Canonico PL, Speciale C, Sortino MA, Cronin MJ, MacLeod RM, Scapagnini U.
    Life Sci; 1986 Jan 20; 38(3):267-72. PubMed ID: 2867452
    [Abstract] [Full Text] [Related]

  • 10. The inhibition of growth hormone release by gastrin-releasing peptide involves somatostatin release.
    Kentroti S, Aguila MC, McCann SM.
    Endocrinology; 1988 Jun 20; 122(6):2407-11. PubMed ID: 2897283
    [Abstract] [Full Text] [Related]

  • 11. Novel hypothalamic arachidonate products stimulate somatostatin release from the median eminence.
    Capdevila J, Chacos N, Falck JR, Manna S, Negro-Vilar A, Ojeda SR.
    Endocrinology; 1983 Jul 20; 113(1):421-3. PubMed ID: 6134613
    [Abstract] [Full Text] [Related]

  • 12. GRF increases release of growth hormone and arachidonate from anterior pituitary cells.
    Judd AM, Koike K, MacLeod RM.
    Am J Physiol; 1985 Apr 20; 248(4 Pt 1):E438-42. PubMed ID: 2858979
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus.
    Junier MP, Tiberghien C, Rougeot C, Fafeur V, Dray F.
    Endocrinology; 1988 Jul 20; 123(1):72-80. PubMed ID: 2898362
    [Abstract] [Full Text] [Related]

  • 14. Arachidonate stimulates prolactin release in vitro: a role for the fatty acid and its metabolites as intracellular regulator(s) in mammotrophs.
    Canonico PL, Judd AM, Koike K, Valdenegro CA, MacLeod RM.
    Endocrinology; 1985 Jan 20; 116(1):218-25. PubMed ID: 2981065
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Somatostatin prevents the desensitizing action of growth hormone-releasing factor on growth hormone release.
    Simard J, Lefèvre G, Labrie F.
    Peptides; 1987 Jan 20; 8(2):199-205. PubMed ID: 2884644
    [Abstract] [Full Text] [Related]

  • 17. Phospholipase-A2 action and arachidonic acid metabolism in calcium-mediated parathyroid hormone secretion.
    Bourdeau A, Souberbielle JC, Bonnet P, Herviaux P, Sachs C, Lieberherr M.
    Endocrinology; 1992 Mar 20; 130(3):1339-44. PubMed ID: 1537295
    [Abstract] [Full Text] [Related]

  • 18. Somatostatin decreases somatostatin messenger ribonucleic acid levels in the rat periventricular nucleus.
    Aguila MC.
    Peptides; 1998 Mar 20; 19(9):1573-9. PubMed ID: 9864065
    [Abstract] [Full Text] [Related]

  • 19. Arachidonic acid metabolism and thyrotropin secretion in vitro.
    Canonico PL, Valdenegro CA, Judd AM, MacLeod RM.
    Eur J Pharmacol; 1984 Feb 10; 98(1):45-52. PubMed ID: 6425068
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the glucose-dependent release of growth hormone-releasing factor and somatostatin from superfused rat hypothalami.
    Baes M, Vale WW.
    Neuroendocrinology; 1990 Feb 10; 51(2):202-7. PubMed ID: 1968236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.